Hans-Georg Strauss

Hans-Georg Strauss

UNVERIFIED PROFILE

Are you Hans-Georg Strauss?   Register this Author

Register author
Hans-Georg Strauss

Hans-Georg Strauss

Publications by authors named "Hans-Georg Strauss"

Are you Hans-Georg Strauss?   Register this Author

15Publications

543Reads

41Profile Views

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.

Gynecol Oncol 2019 05 11;153(2):286-291. Epub 2019 Feb 11.

Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Germany; Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.02.007DOI Listing
May 2019

The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.

Nucleic Acids Res 2016 05 24;44(8):3845-64. Epub 2016 Feb 24.

Institute of Molecular Medicine, Section for Molecular Cell Biology, Faculty of Medicine, Martin-Luther-University Halle Wittenberg, ZAMED, Heinrich-Damerow-Str.1, 06120 Halle, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856984PMC
May 2016

Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.

J Natl Cancer Inst 2015 Mar 24;107(3). Epub 2015 Jan 24.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (SM, LFG, LW); Department of Obstetrics and Gynecology, University Hospital Munich Maistrasse, Munich, Germany (JJ); Department of Obstetrics and Gynecology, University Medical Center Kiel, Kiel, Germany (FH); KKS Philipps University Marburg, Marburg, Germany (PN); Department of Gynecology and Gynecologic Oncology Kliniken Essen-Mitte, Essen, Germany (PH, AdB); Department of Obstetrics and Gynecology, University of Ulm Medical Center, Ulm, Germany (NdG); Department of Gynecology and Gynecologic Oncology, University Hospital Freiburg, Freiburg, Germany (AHas); Department of Gynecology, Charité University Medicine Berlin Campus Virchow, Berlin, Germany (JS); Department of Obstetrics and Gynecology, University Hospital Magdeburg, Magdeburg, Germany (AHab); Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany (PH); Department of Obstetrics and Gynecology, Grosshadern University Hospital, Munich, Germany (SF); Department of Gynecology, University Hospital Halle, Halle, Germany (HGS); Department of Gynecology and Gynecologic Oncology, Philipps University Marburg, Marburg, Germany (KB); Department of Gynecology, University Hospital Erlangen, Erlangen, Germany (FT); Department of Obstetrics and Gynecology, University Hospital Greifswald, Greifswald, Germany (AM); Department of Obstetrics and Gynecology, Evangelical Hospital Duesseldorf, Duesseldorf, Germany (WM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356703PMC
March 2015

Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer.

Anticancer Drugs 2008 Jun;19(5):541-5

Department of Gynecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3282fcbbf7DOI Listing
June 2008